Skip to main content
SpringerLink
Log in

The Controversy That Will Not Go Away: Vaccines and Autism

  • Chapter
  • First Online:
Vaccinophobia and Vaccine Controversies of the 21st Century

Abstract

It is generally accepted that the number of new autism diagnoses is increasing. It is unclear whether this is due to a true increase in cases, increasing awareness of autism spectrum disorders (ASDs), or differences in the methods used to diagnose these conditions and assess their prevalence. The burden of ASDs for families and communities is considerable both monetarily and emotionally. In the first few decades after autism was described, it was thought to be a consequence of bad parenting, particularly by the mother. Despite decades of research, a specific scientific cause or definitive treatment for ASDs remains elusive in most cases. This lack of evidence has led to much speculation about the etiology of ASDs. Early reports of associations between the MMR vaccine and autism have been shown to be based on flawed and perhaps fraudulent studies. Similarly, reports linking the mercury-containing preservative thimerosal with autism have been refuted by several rigorously conducted scientific studies. The third theory that vaccines either “weaken” or “overwhelm” the immature immune system in young children and lead to autism is also not supported by credible scientific data. Emerging research indicates the genetic underpinnings of ASDs, but a small, vocal minority of parent groups and even a few physicians and scientists continue to support the hypothesis that vaccines cause autism. Unsubstantiated media reports and litigation sponsored by some parent advocacy groups continue to keep the controversy alive. Vaccines have been phenomenally successful in eliminating diseases such as smallpox, measles, and polio. Fear of these deadly scourges has been replaced with concerns about vaccine safety among some members of the public. Declining vaccination rates have caused a reemergence of some of these diseases. In order to reestablish the public’s trust in vaccination, it is imperative that rigorously researched scientific information on the issue of vaccines and autism is accurately collected and appropriately disseminated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Williams R. Autism through ages baffles science. Available at: http://pediatricservices.com/prof/prof-26.htm. Accessed 10 Feb 2012.

  2. Kanner L. Autistic disturbances of affective contact. Nerv Child. 1943;2:217–50.

    Google Scholar 

  3. Weintraub K. The prevalence puzzle: Autism counts. Nature. 2011;479(7371):22–4.

    Article  CAS  PubMed  Google Scholar 

  4. Pervasive Developmental Disorders. In: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition, text revision (DSM-IV-TR). American Psychiatric Association, Washington, DC 2000. p. 70

  5. DSM-5 proposed criteria for autism spectrum disorder designed to provide more accurate diagnosis and treatment. Available at: http://www.dsm5.org/Documents/12-03%20Autism%20Spectrum%20Disorders%20-%20DSM5.pdf. Accessed 30 Jan 2012.

  6. Refrigerator Mothers. Available at: http://kartemquin.com/films/refrigerator-mothers. Accessed 30 Jan 2012.

  7. Kanner L. Problems of nosology and psychodynamics in early childhood autism. Am J Orthopsychiatry. 1949;19(3):416–26.

    Article  CAS  PubMed  Google Scholar 

  8. Bettenheim B. The empty fortress: infantile autism and the birth of the self. New York: The Free Press; 1967.

    Google Scholar 

  9. Laidler JR. The “Refrigerator Mother” hypothesis of autism. Available at: http://www.autism-watch.org/causes/rm.shtml. Accessed 30 Jan 2012

  10. Rimland B. Infantile autism: The syndrome and its implications for a neural theory of behavior. New Jersey, NJ: Prentice Hall; 1964.

    Google Scholar 

  11. Rutter M, Greenfeld D, Lockyer L. A five to fifteen year follow-up study of infantile psychosis. II. Social and behavioural outcome. Br J Psychiatry. 1967;113(504):1183–99.

    Article  CAS  PubMed  Google Scholar 

  12. Rutter M. Concepts of autism: a review of research. J Child Psychol Psychiatry. 1968;9(1):1–25.

    Article  CAS  PubMed  Google Scholar 

  13. Lotter V. Epidemiology of autistic conditions in young children. Soc Psychiatry Psychiatr Epidemiol. 1966;1:124–37.

    Google Scholar 

  14. Autism and Developmental Disabilities Monitoring Network Principal Investigators. Prevalence of autism spectrum disorders -Autism and developmental disabilities monitoring network, United States, 2006. MMWR. 2009;58(SS10):1–24.

    Google Scholar 

  15. Brugha TS, McManus S, Bankart J, et al. Epidemiology of autism spectrum disorders in adults in the community in England. Arch Gen Psychiatry. 2011;68(5):459–65.

    Article  PubMed  Google Scholar 

  16. Novella S. The increase in autism diagnoses: Two hypotheses. Available at: http://www.sciencebasedmedicine.org/index.php/the-increase-in-autism-diagnoses-two-hypotheses/ Accessed 30 Jan 2012.

  17. Fombonne E. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry. 2005;66 Suppl 10:3–8.

    PubMed  Google Scholar 

  18. Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr. 2005;94(1):2–15.

    Article  CAS  PubMed  Google Scholar 

  19. Shattuck PT. The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education. Pediatrics. 2006;117(4):1028–37.

    Article  PubMed  Google Scholar 

  20. Jick H, Kaye JA. Epidemiology and possible causes of autism. Pharmacotherapy. 2003;23(12):1524–30.

    Article  PubMed  Google Scholar 

  21. Taylor B. Vaccines and the changing epidemiology of autism. Child Care Health Dev. 2006;32(5):511–9.

    Article  CAS  PubMed  Google Scholar 

  22. Ludlow A, Skelly C, Rohleder P. Challenges faced by parents of children diagnosed with autism spectrum disorder. J Health Psychol. 2012;17(5):702–11.

    Article  PubMed  Google Scholar 

  23. Johnson N, Frenn M, Feetham S, Simpson P. Autism spectrum disorder: parenting stress, family functioning and health-related quality of life. Fam Syst Health. 2011;29(3):232–52.

    Article  PubMed  Google Scholar 

  24. Autism and family stress. Personal Best Healthlines. 2011. Available at: http://www.personalbest.com/Health-Wellness/Newsletters/PersonalBest4U-Online-Newsletter.aspx. Accessed 31 Jan 2012.

  25. Montes G, Halterman JS. Association of childhood autism spectrum disorders and loss of family income. Pediatrics. 2008;121(4):e821–6.

    Article  PubMed  Google Scholar 

  26. Montes G, Halterman JS. Child care problems and employment among families with preschool-aged children with autism in the United States. Pediatrics. 2008;122(1):e202–8.

    Article  PubMed  Google Scholar 

  27. O’ Brien I, Duffy A, Nicholl H. Impact of childhood chronic illnesses on siblings: a literature review. Br J Nurs. 2009;18(22):358, 1360–5.

    Google Scholar 

  28. Rao PA, Beidel DC. The impact of children with high-functioning autism on parental stress, sibling adjustment, and family functioning. Behav Modif. 2009;33(4):437–51.

    Article  PubMed  Google Scholar 

  29. Paul R, editor. Natural history. In: Handbook of Autism and Pervasive Developmental Disorders. John Wiley & Sons, Inc.; 1987. p. 121–3.

    Google Scholar 

  30. Ganz ML. The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med. 2007;161(4):343–9.

    Article  PubMed  Google Scholar 

  31. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism. 2009;13(3):317–36.

    Article  PubMed  Google Scholar 

  32. Wassink TH, Brzustowicz LM, Bartlett CW, Szatmari P. The search for autism disease genes. Ment Retard Dev Disabil Res Rev. 2004;10(4):272–83.

    Article  PubMed  Google Scholar 

  33. Orsmond GI, Seltzer MM. Siblings of individuals with autism spectrum disorders across the life course. Ment Retard Dev Disabil Res Rev. 2007;13(4):313–20.

    Article  PubMed  Google Scholar 

  34. Barton M, Volkmar F. How commonly are known medical conditions associated with autism? J Autism Dev Disord. 1998;28(4):273–8.

    Article  CAS  PubMed  Google Scholar 

  35. Eapen V. Genetic basis of autism: is there a way forward? Curr Opin Psychiatry. 2011;24(3):226–36.

    Article  PubMed  Google Scholar 

  36. Ratajczak HV. Theoretical aspects of autism: causes–a review. J Immunotoxicol. 2011;8(1):68–79.

    Article  PubMed  Google Scholar 

  37. Becker KG, Schultz ST. Similarities in features of autism and asthma and a possible link to acetaminophen use. Med Hypotheses. 2010;74(1):7–11.

    Article  CAS  PubMed  Google Scholar 

  38. Lawler CP, Croen LA, Grether JK, Van de Water J. Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev. 2004;10(4):292–302.

    Article  PubMed  Google Scholar 

  39. Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M, et al. Breastfeeding, infant formula supplementation, and autistic disorder: the results of a parent survey. Int Breastfeed J. 2006;1:16.

    Article  PubMed  Google Scholar 

  40. Demirjian A, Levy O. Novel vaccines: bridging research, development and production. Expert Rev Vaccines. 2008;7:1321–4.

    Article  CAS  PubMed  Google Scholar 

  41. Oxford JS. The end of the beginning: vaccines for the next 25 years. Vaccine. 2008;26:6179–82.

    Article  CAS  PubMed  Google Scholar 

  42. Plotkin SL, Plotkin SA. A short history of vaccination. In: Plotkin SA, Orenstein W, Offit P, editors. Vaccines. 5th ed. Philadelphia, PA: Saunders-Elsevier; 2008. p. 1–16.

    Google Scholar 

  43. Hinman AR, Orenstein WA, Schuchat A. Vaccine-preventable diseases, immunizations, and MMWR — 1961–2011. MMWR. 2011;60:49–57.

    PubMed  Google Scholar 

  44. Jana L. Don’t take the benefits of vaccines for granted. Omaha World Herald. 2011(April 12).

    Google Scholar 

  45. Gupta VB. Communicating with parents of children with autism about vaccines and complementary and alternative approaches. J Dev Behav Pediatr. 2010;31:343–5.

    Article  PubMed  Google Scholar 

  46. Chatterjee A, Moffatt K. Vaccines and autism—an unlikely connection. In: Eapen V, editor. Autism—A neurodevelopmental journey from genes to behaviour. Rijeka, Croatia: Intech; 2011. p. 319–42.

    Google Scholar 

  47. Coulter HL, Fisher BL. A shot in the dark. Why the P in the DPT vaccination may be hazardous to your child’s health. Garden City Park, NY: Avery Pub. Group; 1991.

    Google Scholar 

  48. Wakefield AJ, Murch SH, Linnell J, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [retracted]. Lancet. 1998;351:637–41.

    Article  CAS  PubMed  Google Scholar 

  49. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hashika A, Wakefield A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci. 2000;45:723–9.

    Article  CAS  PubMed  Google Scholar 

  50. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet. 1998;351:611–2.

    Article  CAS  PubMed  Google Scholar 

  51. Payne C, Mason B. Autism, inflammatory bowel disease, and MMR vaccine. Lancet. 1998;351:907.

    Article  CAS  PubMed  Google Scholar 

  52. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002;347:1477–82.

    Article  PubMed  Google Scholar 

  53. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ. 2002;324:393–6.

    Article  PubMed  Google Scholar 

  54. Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case–control study using data from the UK General Practice Research Database. BMJ. 2002;325:419–21.

    Article  PubMed  Google Scholar 

  55. Honda H, Shimizu Y, Rutter M. No effect of MMR withdrawal on the incidence of autism: a total population study. J Child Psychol Psychiatry. 2005;46:572–9.

    Article  PubMed  Google Scholar 

  56. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, et al. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet. 1998;351:1327–8.

    Article  CAS  PubMed  Google Scholar 

  57. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026–9.

    Article  CAS  PubMed  Google Scholar 

  58. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, et al. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000;19:1127–34.

    Article  CAS  PubMed  Google Scholar 

  59. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA. 2001;285:1183–5.

    Article  CAS  PubMed  Google Scholar 

  60. Smeeth L, Hall AJ, Fombonne E, Rodrigues LC, Huang X, et al. A case–control study of autism and mumps-measles-rubella vaccination using the general practice research database: design and methodology. BMC Public Health. 2001;1:2.

    Article  CAS  PubMed  Google Scholar 

  61. Takahashi H, Arai S, Tanaka-Taya K, Okabe N. Autism and infection/immunization episodes in Japan. Jpn J Infect Dis. 2001;54:78–9.

    CAS  PubMed  Google Scholar 

  62. Fombonne E, Chakrabarti S. No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics. 2001;108:E58.

    Article  CAS  PubMed  Google Scholar 

  63. Kaye JA, del Mar M-MM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ. 2001;322:460–3.

    Article  CAS  PubMed  Google Scholar 

  64. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine. 2001;19:3632–5.

    Article  CAS  PubMed  Google Scholar 

  65. Makela A, Nuorti JP, Peltola H. Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics. 2002;110:957–63.

    Article  PubMed  Google Scholar 

  66. Lingam R, Simmons A, Andrews N, Miller E, Stowe J, et al. Prevalence of autism and parentally reported triggers in a north east London population. Arch Dis Child. 2003;88:666–70.

    Article  CAS  PubMed  Google Scholar 

  67. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, et al. MMR vaccination and pervasive developmental disorders: a case–control study. Lancet. 2004;364:963–9.

    Article  PubMed  Google Scholar 

  68. Chen W, Landau S, Sham P, Fombonne E. No evidence for links between autism, MMR and measles virus. Psychol Med. 2004;34:543–53.

    Article  CAS  PubMed  Google Scholar 

  69. Klein K, Diehl E. Relationship between MMR vaccine and autism. Ann Pharmacother. 2004;38:1297–300.

    Article  PubMed  Google Scholar 

  70. DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics. 2004;113:259–66.

    Article  PubMed  Google Scholar 

  71. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics. 2006;118:e139–50.

    Article  PubMed  Google Scholar 

  72. Richler J, Luyster R, Risi S, Hsu WL, Dawson G, et al. Is there a ‘regressive phenotype’ of Autism Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J Autism Dev Disord. 2006;36:299–316.

    Article  PubMed  Google Scholar 

  73. Uchigama T, Kurosawa M, Inaba Y. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J Autism Dev Disord. 2007;37:210–7.

    Article  Google Scholar 

  74. Mroz˙ek-Budzyn D, Kiełtyka A, Majewska R. Lack of association between measles-mumps-rubella vaccination and autism in children. A case–control study. Pediatr Infect Dis J. 2010;29:397–400.

    Article  Google Scholar 

  75. DeStefano F. Vaccines and autism: evidence does not support a causal association. Clin Pharmacol Ther. 2007;82:756–9.

    Article  CAS  PubMed  Google Scholar 

  76. Gerber JS, Offit A. Vaccines and autism: A tale of shifting hypotheses. Clin Infect Dis. 2009;48(4):456–61.

    Article  PubMed  Google Scholar 

  77. Miller L, Reynolds J. Autism and vaccination-The current evidence. J Spec Pediatr Nurs. 2009;14:166–72.

    Article  PubMed  Google Scholar 

  78. Hensley E, Briars L. Closer look at autism and the measles–mumps–rubella vaccine. J Am Pharm Assoc. 2010;50:736–41.

    Article  Google Scholar 

  79. Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed by permanent injury or death associated with further attenuated measles vaccines: A review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics. 1998;101:383–7.

    Article  CAS  PubMed  Google Scholar 

  80. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev. 2000;19:265–83.

    CAS  PubMed  Google Scholar 

  81. Geier MR, Geier DA. Pediatric MMR vaccination safety. International Pediatrics. 2003;18:203–8.

    Google Scholar 

  82. Murch SH, Anthony A, Casson DH, Malik M, Berelowitz M, Dhillon AP, et al. Retraction of an interpretation. Lancet. 2004;363:750.

    Article  PubMed  Google Scholar 

  83. D’Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics. 2006;118:1664–75.

    Article  PubMed  Google Scholar 

  84. Afzal MA, Ozoemena LC, O’Hare A, Kidger KA, Bentley ML, et al. Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK. J Med Virol. 2006;78:623–30.

    Article  CAS  PubMed  Google Scholar 

  85. Baird G, Pickles A, Simonoff E, Charman T, Sullivan P, Chandler S, et al. Measles vaccination and antibody response in autism spectrum disorders. Arch Dis Child. 2008;93(10):832–7.

    Article  CAS  PubMed  Google Scholar 

  86. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, et al. Lack of association between measles virus vaccine and autism with enteropathy: a case–control study. PLoS One. 2008;3(9):e3140.

    Article  PubMed  CAS  Google Scholar 

  87. Institute of Medicine. Immunization safety review: vaccines and autism. Available at: http://www.nap.edu/catalog.php?record_id=10997. Accessed 12 Feb 2012.

  88. Fisher BL. Vaccines, autism & chronic inflammation: The new epidemic. Inc: PB Industries; 2008.

    Google Scholar 

  89. BBC News. MMR immunisation rate falls again. Available at: http://news.bbc.co.uk/2/hi/health/3683930.stm. Accessed 14 Feb 2012.

  90. McIntyre P, Leask J. Improving uptake of MMR vaccine. BMJ. 2008;336:729–30.

    Article  PubMed  Google Scholar 

  91. Murphy JF. Fallout of the enterocolitis, autism, MMR vaccine paper. Ir Med J. 2011;104(2):36.

    CAS  PubMed  Google Scholar 

  92. Asaria P, MacMahon E. Measles in the United Kingdom: can we eradicate it by 2010? BMJ. 2006;333:890–5.

    Article  PubMed  Google Scholar 

  93. Gupta RK, Best J, MacMahon E. Mumps and the UK epidemic 2005. BMJ. 2005;330:1132–5.

    Article  PubMed  Google Scholar 

  94. Centers for Disease Control and Prevention (CDC). Mumps epidemic--United Kingdom, 2004-2005. MMWR 2006;55:173-5.

    Google Scholar 

  95. Editorial team. Measles once again endemic in the United Kingdom. Euro Surveill 2008;13(27):pii=18919. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18919. Accessed 14 Feb 2012.

  96. Pepys MB. Science and serendipity. Clin Med. 2007;7:562–78.

    Article  PubMed  Google Scholar 

  97. McBrien J, Murphy J, Gill D, Cronin M, O’Donovan C, Cafferkey MT. Measles outbreak in Dublin, 2000. Pediatr Infect Dis J. 2003;22(7):580–4.

    PubMed  Google Scholar 

  98. BBC News. MMR vaccine uptake rise ‘stalls’. Available at: http://news.bbc.co.uk/2/hi/health/7633115.stm. Accessed 10 Apr 2011.

  99. Smith MJ, Ellenberg SS, Bell LM, Rubin DM. Media coverage of the measles-mumps-rubella vaccine and autism controversy and its relationship to MMR immunization rates in the United States. Pediatrics. 2008;121:e836–43.

    Article  PubMed  Google Scholar 

  100. Parker Fiebelkorn A, Redd SB, Gallagher K, et al. Measles in the United States during the postelimination era. J Infect Dis. 2010;202:1520–8.

    Article  PubMed  Google Scholar 

  101. Centers for Disease Control and Prevention. Update: Measles --- United States, January--July 2008. MMWR 2008;57:893-896.

    Google Scholar 

  102. Centers for Disease Control and Prevention (CDC). Hospital-associated measles outbreak—Pennsylvania, March-April 2009. MMWR Morb Mortal Wkly Rep. 2012;61:30-2.

  103. Hampton T. Outbreaks spur measles vaccine studies. JAMA. 2011;306(22):2440–2.

    Article  CAS  PubMed  Google Scholar 

  104. Centers for Disease Control and Prevention (CDC). Notes from the field: Measles outbreak--Indiana, June-July 2011. MMWR Morb Mortal Wkly Rep 2011;60(34):1169.

  105. Moss WJ, Griffin DE. Measles. Lancet. 2012;379(9811):153–64.

    Article  PubMed  Google Scholar 

  106. Chen SY, Anderson S, Kutty PK, et al. Healthcare-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis. 2011;203:1517–25.

    Article  PubMed  Google Scholar 

  107. Centers for Disease Control and Prevention (CDC). Notes from the field: Measles outbreak--Hennepin County, Minnesota, February-March 2011. MMWR Morb Mortal Wkly Rep 2011;60(13):421.

  108. Centers for Disease Control and Prevention (CDC). Measles: United States, January--May 20, 2011. MMWR Morb Mortal Wkly Rep. 2011;60(20):666-8.

  109. Godlee F, Smith J, Markovitch H. Wakefield’s article linking MMR vaccine and autism was fraudulent. Clear evidence of falsification of data should now close the door on this damaging vaccine scare. BMJ. 2011;342:c7452.

    Google Scholar 

  110. Deer B. Secrets of the MMR scare. How the case against the MMR vaccine was fixed. BMJ. 2011;342:c5347.

    Google Scholar 

  111. Deer B. Secrets of the MMR scare. How the vaccine crisis was meant to make money. BMJ. 2011;342:c5258.

    Google Scholar 

  112. Deer B. Secrets of the MMR scare. The Lancet’s two days to bury bad news. BMJ. 2011;342:c7001.

    Article  PubMed  Google Scholar 

  113. Office of Research Integrity. Definition of research misconduct. Available at: http://ori.hhs.gov/definition-misconduct. Accessed 14 Feb 2012.

  114. Deer B. Revealed: MMR research scandal. Sunday Times 2004 February 22. Available at: www.timesonline.co.uk/tol/life_and_style/health/article1027636.ece. Accessed 17 Apr 2011.

  115. The editors of the Lancet. Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 2010;375:445.

    Google Scholar 

  116. Transcripts of hearings of fitness to practice panel (misconduct) in the case of Wakefield, Walker-Smith, and Murch, 16 July 2007 to 24 May 2010. GMC; 2010.

    Google Scholar 

  117. General Medical Council. Dr Andrew Jeremy Wakefield. Determination on serious professional misconduct (SPM) and sanction. 24 May 2010. Available at: www.gmc-uk.org/Wakefield_SPM_and_SANCTION.pdf_32595267.pdf. Accessed 17 Apr 2011.

  118. General Medical Council. Professor John Angus Walker-Smith. Determination on serious professional misconduct (SPM) and sanction. 24 May 2010. http://www.gmc-uk.org/Professor_Walker_Smith_SPM.pdf_32595970.pdf. Accessed 17 Apr 2011.

  119. Offit PA. Autism’s false prophets. Bad science, risky medicine, and the search for a cure. New York, NY: Columbia University Press; 2008.

    Google Scholar 

  120. Offit PA. Deadly choices. How the anti-vaccine movement threatens us all. Basic Books, NY, USA; 2011.

    Google Scholar 

  121. Mnookin S. The Panic Virus. A true story of medicine, science and fear. New York, USA: Simon and Schuster; 2011.

    Google Scholar 

  122. Dillner L. Regulating research. BMJ. 2010;341:c5128.

    Google Scholar 

  123. Wager L. Wakefield: should we demand public access to raw data? BMJ. 2011;342:135.

    Article  Google Scholar 

  124. Opel DJ, Diekema DS, Marcuse EK. Assuring research integrity in the wake of Wakefield. BMJ. 2011;342:179–80.

    Article  Google Scholar 

  125. Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green J, Long SJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine. 2010;28(26):4235–48.

    Article  PubMed  Google Scholar 

  126. Casiday R, Cresswell T, Wilson D, Panter-Brick C. A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine. 2006;24(2):177–84.

    Article  PubMed  Google Scholar 

  127. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Parental vaccine safety concerns in 2009. Pediatrics. 2010;125(4):654–9.

    Article  PubMed  Google Scholar 

  128. Brown KF, Long SJ, Ramsay M, Hudson MJ, Green J, Vincent CA, et al. UK parents’ decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: A qualitative analysis. Vaccine. 2012;30(10):1855–64.

    Article  PubMed  Google Scholar 

  129. Baker JP. Mercury, vaccines, and autism: one controversy, three histories. Am J Public Health. 2008;98:244–53.

    Article  PubMed  Google Scholar 

  130. United States Environmental Protection Agency. Implementation of the Mercury-Containing and Rechargeable Battery Management Act. Available at: http://www.epa.gov/osw/hazard/recycling/battery.pdf. Accessed 14 Feb 2012.

  131. United States Environmental Protection Agency. Methyl mercury. Available at: http://www.epa.gov/iris/subst/0073.htm#reforal Accessed 14 Feb 2012.

  132. United States Enviromental Protection Agency. Health Effects. Mercury. Available at: http://www.epa.gov/hg/effects.htm#comp. Accessed 14 Feb 2012.

  133. Mahaffey KR, Rice G, et al. An assessment of exposure to mercury in the United States: Mercury study report to Congress. Washington, DC: US Environmental Protections Agency; 1997. Document EPA-452/R097-006.

    Google Scholar 

  134. Mahaffey KR. Methylmercury: A new look at the risks. Public Health Rep. 1999;114:397–413.

    Article  Google Scholar 

  135. Agency for Toxic Substances and Disease Registry. Toxicological profile for mercury. Atlanta, GA: Agency for Toxic Substances and Disease Registry;1999.

    Google Scholar 

  136. Federal Register, January 19, 1979;44;3990.

    Google Scholar 

  137. World Health Organization. Trace elements and human nutrition and health. Geneva: World Health Organization; 1996. p. 209.

    Google Scholar 

  138. United States Food and Drug Administration. Thimerosal in vaccines. Available at: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/UCM096228#guid. Accessed 14 Feb 2012

  139. 21 USC 397 Section 413, 1997.

    Google Scholar 

  140. Ball LK, Ball R, Pratt RD. An assessment of thimerosal use in childhood vaccines. Pediatrics. 2001;107(5):1147–54.

    Article  CAS  PubMed  Google Scholar 

  141. Centers for Disease Control and Prevention. Notice to Readers: Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public Health Service. MMWR. 1999;48:563–5.

    Google Scholar 

  142. Centers for Disease Control and Prevention. Notice to Readers: Summary of the Joint Statement on Thimerosal in Vaccines. MMWR. 2000;49(27):622–31.

    Google Scholar 

  143. Offit PA. Thimerosal and vaccines–a cautionary tale. N Engl J Med. 2007;357(13):1278–9.

    Article  CAS  PubMed  Google Scholar 

  144. Rimland B. The vaccine-autism connection-Part I (Thimerosal). Available at: www.Autism Research Institute.com. Accessed 14 Feb 2012.

  145. Nelson KB, Bauman ML. Thimerosal and autism? Pediatrics. 2003;111:674–9.

    Article  PubMed  Google Scholar 

  146. Blood and hair mercury levels in young children and women of childbearing age—United States, 1999. MMWR 50(8):140–143.

    Google Scholar 

  147. Institute of Medicine. Thimerosal-containing vaccines and neurodevelopmental disorders. Washington, D.C: National Academy Press; 2001.

    Google Scholar 

  148. Mutter J, Naumann J, Schneider R, Walach H, Haley B. Mercury and autism: accelerating evidence? Neuro Endocrinol Lett. 2005;26(5):439–46.

    PubMed  Google Scholar 

  149. Geier MR, Geier DA. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med. 2003;228:660–4.

    CAS  Google Scholar 

  150. Geier DA, Geier MR. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatr Rehabil. 2003;6(2):97–102.

    PubMed  Google Scholar 

  151. Geier DA, Geier MR. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit. 2004;10(3):I33–9.

    Google Scholar 

  152. Geier DA, Geier MR. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis. Int J Toxicol. 2004;23(6):369–76.

    Article  CAS  PubMed  Google Scholar 

  153. Geier DA, Geier MR. An evaluation of the effects of thimerosal on neurodevelopmental disorders reported following DTP and Hib vaccines in comparison to DTPH vaccine in the United States. J Toxicol Environ Health. 2006;69:1481–95.

    Article  CAS  Google Scholar 

  154. Geier DA, Geier MR. A prospective study of thimerosal-containing Rho(D)-immune globulin administration as a risk factor for autistic disorders. J Matern Fetal Neonatal Med. 2007;20:358–90.

    Article  CAS  Google Scholar 

  155. Goodman MJ, Nordin J. Vaccine Adverse Event Reporting System source: a possible source of bias in longitudinal studies. Pediatrics. 2006;117:387–90.

    Article  PubMed  Google Scholar 

  156. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA. 2003;290(13):1763–6.

    Article  CAS  PubMed  Google Scholar 

  157. Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, et al. Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics. 2003;112(3 Pt 1):604–6.

    Article  PubMed  Google Scholar 

  158. Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am J Prev Med. 2003;25(2):101–6.

    Article  PubMed  Google Scholar 

  159. Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, et al. Chen RT; Vaccine Safety Datalink Team. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics. 2003;112(5):1039–48.

    Google Scholar 

  160. Andrews N et al. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;114(3):584–91.

    Article  PubMed  Google Scholar 

  161. Heron J, Golding J. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics. 2004;114(3):577–83.

    Article  PubMed  Google Scholar 

  162. Jick H, Kaye JA. Autism and DPT vaccination in the United Kingdom. N Engl J Med. 2004;350(26):2722–3.

    Article  CAS  PubMed  Google Scholar 

  163. Clements CJ. The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine. 2004;22:1854–61.

    Article  CAS  PubMed  Google Scholar 

  164. Thompson WW, Price C, Goodson B, et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med. 2007;357:1281–92.

    Article  CAS  PubMed  Google Scholar 

  165. Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D’Elia L, Chiarotti F, et al. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines. Pediatrics. 2009;123(2):475–82.

    Article  PubMed  Google Scholar 

  166. Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, Hinrichsen VL, et al. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics. 2010;126(4):656–64.

    Article  PubMed  Google Scholar 

  167. Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention. Immunization Safety Review: Vaccines and Autism. Institute of Medicine of the National Academies. Washington, DC: The National Academies Press; 2004.

    Google Scholar 

  168. Harry GJ, Harris MW, Burka LT. Mercury concentrations in brain and kidney following ethylmercury, methylmercury and thimerosal administration to neonatal mice. Toxicol Lett. 2004;154(3):183–9.

    Article  CAS  PubMed  Google Scholar 

  169. Burbacher TM et al. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect. 2005;113(8):1015–21.

    Article  CAS  PubMed  Google Scholar 

  170. Pichichero ME et al. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet. 2002;360:1737–41.

    Article  CAS  PubMed  Google Scholar 

  171. Aschner M, Ceccatelli S. Are neuropathological conditions relevant to ethylmercury exposure? Neurotox Res. 2010;18:59–68.

    Article  PubMed  Google Scholar 

  172. Shultz ST. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature. Acta Neurobiol Exp. 2010;70:187–95.

    Google Scholar 

  173. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008;57(RR07):1–60.

    PubMed  Google Scholar 

  174. Biroscak BJ, Fiore AE, Fasano N, Fineis P, Collins MP, Stoltman G. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan. Pediatrics. 2003;11:e645–9.

    Article  Google Scholar 

  175. Offit PA. Vaccines and autism revisited-the Hannah Poling case. N Engl J Med. 2008;358:2089–91.

    Article  CAS  PubMed  Google Scholar 

  176. Kennedy JS, Lawrence DA. Coincidental associations do not provide proof for the etiology of autism. J Immunotoxicol. 2011;8(3):198–203.

    Article  PubMed  Google Scholar 

  177. Dingle JH, Badger GF, Jordan WS. Illness in the home: a study of 25,000 illnesses in a group of Cleveland families. Cleveland: Press of Western Reserve University; 1964.

    Google Scholar 

  178. Offit PA, Quarles J, Gerber MA, et al. Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics. 2002;109:124–9.

    Article  PubMed  Google Scholar 

  179. King GE, Hadler SC. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J. 1994;13:394–407.

    Article  CAS  PubMed  Google Scholar 

  180. Black SB, Cherry JD, Shinefield HR, Fireman B, Christenson P, Lampert D. Apparent decreased risk of invasive bacterial disease after heterologous childhood immunization. Am J Dis Child. 1991;145:746–9.

    CAS  PubMed  Google Scholar 

  181. Davidson M, Letson GW, Ward JI, et al. DTP immunization and susceptibility to infectious diseases: is there a relationship? Am J Dis Child. 1991;145:750–4.

    CAS  PubMed  Google Scholar 

  182. Storsaeter J, Olin P, Renemar B, et al. Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. Pediatr Infect Dis J. 1988;7:637–45.

    Article  CAS  PubMed  Google Scholar 

  183. O’Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000;30:784–9.

    Article  PubMed  Google Scholar 

  184. Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A Streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics. 2000;105:e60.

    Article  CAS  PubMed  Google Scholar 

  185. Al-Ayadhi LY. Autoimmunity in autism spectrum disorders. In: Eapen V, editor. Autism—A neurodevelopmental journey from genes to behaviour. Rijeka, Croatia: Intech; 2011. p. 299–318.

    Google Scholar 

  186. Morrow EM, Yoo SY, Flavell SW, et al. Identifying autism loci and genes by tracing recent shared ancestry. Science. 2008;321:218–23.

    Article  CAS  PubMed  Google Scholar 

  187. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004;113(5):e472–86.

    Article  PubMed  Google Scholar 

  188. Hu H, Chung Y. Genome-wide association studies of copy number variation in autism spectrum disorder. In: Eapen V, editor. Autism—A neurodevelopmental journey from genes to behaviour. Rijeka, Croatia: Intech; 2011. p. 165–82.

    Google Scholar 

  189. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474(7351):380–4.

    Article  CAS  PubMed  Google Scholar 

  190. Sugarman SD. Cases in Vaccine Court-Legal battles over vaccines and autism. N Engl J Med. 2007;357:1275–7.

    Article  CAS  PubMed  Google Scholar 

  191. Stewart AM. When vaccine injury claims go to court. N Engl J Med. 2009;360(24):2498–500.

    Article  CAS  PubMed  Google Scholar 

  192. Silverman RD. Litigation, regulation, and education–protecting the public’s health through childhood immunization. N Engl J Med. 2009;360(24):2500–1.

    Article  CAS  PubMed  Google Scholar 

  193. Riedmann EM. Court finds no Vaccines-autism link. Hum Vaccin. 2010;6:368–72.

    Google Scholar 

  194. Supreme Court of the United States. Russell Bruesewitz et al v. Wyeth et al. No. 09-152. Argued October 12, 2010—Decided February 22, 2011.

  195. Mnookin S. The media and its messages. In: The Panic Virus. A true story of medicine, science and fear. Simon and Schuster, New York, NY 2011, pp 160–9.

    Google Scholar 

  196. Singh J, Hallmayer J, Illes J. Interacting and paradoxical forces in neuroscience and society. Nat Rev Neurosci. 2007;8(2):153–60.

    Article  PubMed  CAS  Google Scholar 

  197. Poland GA, Jacobson RM. The age-old struggle against the antivaccinationists. N Engl J Med. 2011;364:97–9.

    Article  CAS  PubMed  Google Scholar 

  198. Offit PA, Moser CA. The problem with Dr. Bob’s alternative vaccine schedule. Pediatrics. 2009;123:e164–9.

    Article  PubMed  Google Scholar 

  199. Mnookin S. The mercury moms. In: The Panic Virus. A true story of medicine, science and fear. Simon and Schuster. New York, NY 2011, pp 133–145.

    Google Scholar 

  200. Mnookin S. Autism speaks. In: The panic virus. A true story of medicine, science and fear. Simon and Schuster, New York, NY 2011, pp 228–238.

    Google Scholar 

  201. Mnookin S. Jenny McCarthy’s mommy instinct. In: The panic virus. A true story of medicine, science and fear. Simon and Schuster, New York, NY 2011, pp 249–264.

    Google Scholar 

  202. Wadman M. A voice of science. Nature. 2011;479:28–31.

    Article  CAS  PubMed  Google Scholar 

  203. Autism Science Foundation. NAAR founder Eric London resigns from Autism Speaks citing disagreement over vaccine research. Available at: http://autismsciencefoundation.wordpress.com/2009/06/30/naar-founder-eric-london-resigns-from-autism-speaks-citing-disagreement-over-autismvaccine-research/. Accessed 18 Feb 2012.

  204. Lord C. How common is autism? Nature. 2011;474:166–8.

    Article  CAS  PubMed  Google Scholar 

  205. Scahill L, Bearss K. The rise in autism and the mercury myth. J Child Adolesc Psychiatr Nurs. 2009;22:51–3.

    Article  PubMed  Google Scholar 

  206. The mind’s tangled web. Nature 2011;479:5.

    Google Scholar 

  207. Mottron L. Changing perceptions: the power of autism. Nature. 2011;479:33–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Creighton University School of Medicine, Omaha, NE, USA

    Archana Chatterjee M.D., Ph.D.

Authors
  1. Archana Chatterjee M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Archana Chatterjee M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. , School of Medicine, Creighton University, North 30th Street,Suite 6814 601, Omaha, 68131, Nebraska, USA

    Archana Chatterjee

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Chatterjee, A. (2013). The Controversy That Will Not Go Away: Vaccines and Autism. In: Chatterjee, A. (eds) Vaccinophobia and Vaccine Controversies of the 21st Century. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7438-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7438-8_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7437-1

  • Online ISBN: 978-1-4614-7438-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation